Abstract:Objectives: Mammary tumours in cats are biologically aggressive. The standard of care relies upon wide surgical resection. Chemotherapy has been described in the macroscopic disease setting; however, limited efficacy has been shown. The aim of this study was to assess the efficacy of toceranib phosphate in macroscopic feline mammary tumours (FMTs). Methods: A total of 17 cats with cytologically or histopathologically confirmed mammary adenocarcinoma (gross disease) were prospectively enrolled. Toceranib phosphate was administered at a median dose of 2.77 mg/kg (range 2.3-3.2) PO q48 h. No corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs) were administered. Toxicity was graded according to Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE) v1.1 criteria. The response was assessed after 1 month, following Response Evaluation Criteria In Solid Tumours (RECIST) criteria. Results: Toxicity was observed in eight cats, with most instances being grade 1 or 2, which were managed with supportive care. Only one cat experienced grade 3 toxicity (anorexia), which resolved after a dose reduction. Clinical benefit was seen in 12 (64.7%) cats and an objective response was seen in six (35.2%) cats. One cat experienced complete response, five had partial response, six had stable disease and five had progressive disease. One cat showed distant progression (malignant pleural effusion) despite continued partial remission of the primary tumour. The median progression-free survival and median overall survival time were 91 days (range 30-158) and 145 days (range 31-234), respectively. Conclusions and relevance: Toceranib phosphate showed clinical benefit and a good safety profile in advanced or recurrent FMTs, offering a new alternative in the treatment of this disease; however, further prospective and randomised studies are required to further assess its efficacy. Interestingly, one cat developed distant metastases while the primary tumour showed partial response, suggesting that primary tumour and metastatic disease may not sustain the same sensitivity to toceranib.

Glycogen-rich clear cell carcinoma of the feline mammary gland: case report

Malignant Granular Cell Tumor with Breast Metastasis: A Case Report and Review of the Literature

Feline uterine carcinosarcoma infiltrated with osteoclast-like giant cells

Biphasic Feline Mammary Carcinomas Including Carcinoma and Malignant Myoepithelioma

Genetic Alterations in Invasive Breast Carcinoma with a Glycogen-Rich Clear Cell Pattern: A Case Report

Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population

Ciliary body myxoid epithelioid sarcoma in a cat: a case report

Feline Mammary Sarcoma Composed of Cells Resembling Myofibroblasts

Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer

Feline pulmonary carcinoma: Gross, histological, metastatic, and immunohistochemical aspects

Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma

Platelet count and MCHC as independent prognostic markers for feline mammary carcinomas

Immunohistochemical Expression and Prognostic Value of COX-2 and Alpha-Smooth Muscle Actin-positive Cancer-associated Fibroblasts in Feline Mammary Cancer

Thymic squamous cell carcinoma in a cat

The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications

Clinical and Pathological Data of 17 Non-Epithelial Pancreatic Tumors in Cats

Description of a Feline Injection-Site Fibrosarcoma with Metastasis in the Cerebellum

Analysis of serum peptidome profiles of non-metastatic and metastatic feline mammary carcinoma using liquid chromatography-tandem mass spectrometry

Case report: Sclerosing encapsulating peritonitis in a cat with disseminated pancreatic adenocarcinoma of presumed ductal origin

First description of oesophageal melanoma in a cat and palliative treatment by endoscopic argon plasma coagulation laser

Careful Surgery, Management and Treatment of Feline (cat) Breast Cancer